Glynn Capital Management’s AbbVie ABBV Stock Holding History

Glynn Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-14,247	Closed	-$2.64M	–	36
2025 Q2	$2.64M	Sell	14,247 -500	-3%	-$92.9K	0.59%	23
2025 Q1	$3.09M	Hold	14,747	–	–	0.81%	26
2024 Q4	$2.62M	Hold	14,747	–	–	0.62%	25
2024 Q3	$2.91M	Sell	14,747 -10,253	-41%	-$1.91M	0.67%	23
2024 Q2	$4.29M	Hold	25,000	–	–	0.87%	23
2024 Q1	$4.55M	Hold	25,000	–	–	0.85%	25
2023 Q4	$3.87M	Hold	25,000	–	–	0.72%	26
2023 Q3	$3.73M	Hold	25,000	–	–	0.81%	27
2023 Q2	$3.37M	Hold	25,000	–	–	0.75%	25
2023 Q1	$3.98M	Hold	25,000	–	–	0.95%	22
2022 Q4	$4.04M	Hold	25,000	–	–	0.98%	24
2022 Q3	$3.35M	Hold	25,000	–	–	0.72%	27
2022 Q2	$3.83M	Hold	25,000	–	–	0.8%	29
2022 Q1	$4.05M	Hold	25,000	–	–	0.55%	30
2021 Q4	$3.38M	Hold	25,000	–	–	0.36%	32
2021 Q3	$2.7M	Hold	25,000	–	–	0.24%	38
2021 Q2	$2.82M	Hold	25,000	–	–	0.26%	29
2021 Q1	$2.71M	Hold	25,000	–	–	0.26%	29
2020 Q4	$2.68M	Hold	25,000	–	–	0.26%	28
2020 Q3	$2.19M	Hold	25,000	–	–	0.23%	33
2020 Q2	$2.45M	Hold	25,000	–	–	0.31%	27
2020 Q1	$1.91M	Hold	25,000	–	–	0.36%	28
2019 Q4	$2.21M	Hold	25,000	–	–	0.39%	25
2019 Q3	$1.89M	Hold	25,000	–	–	0.35%	27
2019 Q2	$1.82M	Buy	+25,000	New	+$1.96M	0.31%	27

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Glynn Capital Management's ABBV Position: Q3 2025 in Review

Glynn Capital Management sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 14,247 shares — an estimated $2.64M sold.

Glynn Capital Management first reported a position in ABBV in Q2 2019 and held it in 25 quarters. The position peaked at $4.55M in Q1 2024. 3,906 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

Glynn Capital Management reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
Glynn Capital Management sold 14,247 AbbVie shares in Q3 2025, an estimated $2.64M.
Glynn Capital Management first reported a position in AbbVie in Q2 2019 and held it in 25 quarters.
Glynn Capital Management's AbbVie position peaked at $4.55M in Q1 2024.
3,906 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Glynn Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.